Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Study of Ruxolitinib Cream in Children With Atopic Dermatitis

ClinicalTrials.gov ID: NCT05034822

Public ClinicalTrials.gov record NCT05034822. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 12:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Maximum Use (MUsT) Pediatric Study of 1.5% Ruxolitinib Cream in Children (Ages ≥ 2 Years to < 12 Years) With Atopic Dermatitis

Study identification

NCT ID
NCT05034822
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Incyte Corporation
Industry
Enrollment
29 participants

Conditions and interventions

Interventions

  • Ruxolitinib cream Drug

Drug

Eligibility (public fields only)

Age range
2 Years to 11 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 15, 2021
Primary completion
Aug 6, 2023
Completion
Aug 6, 2023
Last update posted
Sep 14, 2023

2021 – 2023

United States locations

U.S. sites
15
U.S. states
11
U.S. cities
15
Facility City State ZIP Site status
Desert Sky Dermatology Gilbert Arizona 85295
Burke Pharmaceutical Research Hot Springs Arkansas 71913
Orange County Research Center Anaheim California 92801
Skin Care Research, Llc Scr Hollywood Hollywood Florida 33021
Accel Clinical Research Lake Mary Florida 32746
San Marcus Research Clinic Inc. Miami Lakes Florida 33014
Forward Clinical Trials Tampa Florida 33624
Advanced Medical Research Pc Sandy Springs Georgia 30328
Aeroallergy Research Lab of Savannah Savannah Georgia 31406
Oakland Hills Dermatology Pc Auburn Hills Michigan 48326
Skin Cancer and Dermatology Institute Reno Nevada 89509
Forest Hills Dermatology Group Forest Hills New York 11375
Ohio Pediatric Research Association Dayton Ohio 45414
Cyn3Rgy Research - Clinedge - Ppds Gresham Oregon 97030
Progressive Clinical Research San Antonio Texas 78213

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05034822, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 14, 2023 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05034822 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →